Angiotensin-Converting Enzyme Genotype in Blacks with Diabetic Nephropathy: Effects on Risk of Diabetes and Its Complications

Journal of Investigative Medicine

Volumn 51, Issue 6, 2003, Pages 360-365

  Crook, Errol D ^a,b,c   Genous, Lori ^a   Oliver, Bonnie ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin converting enzyme polymorphism; Blacks; Diabetic nephropathy; End stage renal disease

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ALLELE; BLOOD PRESSURE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FAMILY HISTORY; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NEGRO; PREDICTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SURVIVAL; UNITED STATES;

INSERTION SEQUENCES;

EID: 0344305429     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.1136/jim-51-06-32     Document Type: Review

References (29)

1. Martins D, Tareen N, Norris KC. The epidemiology of end-stage renal disease among African Americans. Am J Med Sci 2002;323:65-71.
2. Crook ED. Diabetic renal disease in African Americans. Am J Med Sci 2002;323:78-84.
3. Carter JS, Pugh JA, Monterrosa A. Non-insulin-dependent diabetes mellitus in minorities in the United States. Ann Intern Med 1996;125:221-32.
4. Crook ED, Harris J, Oliver B, et al. Endstage renal disease owing to diabetic nephropathy in Mississippi: an examination of factors influencing renal survival in a population prone to late referral. J Invest Med 2001;49:284-91.
5. Brancati FL, Kao WH, Folsom AR, et al. Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. JAMA 2000;283:2253-9.
6. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.
7. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP-1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992;20:1433.
8. Jacobsen P, Rossing K, Rossing P, et al. Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy. Kidney Int 1998;53:1002-6.
9. Parving HH, Jacobsen P, Tarnow L, et al. Effect of the deletion polymorphism of the angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow-up study. BMJ 1996;313:591-4.
10. Fava S, Azzopardi J, Ellard S, Hattersley AT. ACE gene polymorphism as a prognostic indicator in patients with type 2 diabetes and established renal disease. Diabetes Care 2001;24:2115-20.
11. Delos Santos NM, Ault BH, Gharavi AG, et al. Angiotensin-converting enzyme genotype and outcome in pediatric IgA nephropathy. 2002;17:494-502.
12. Forrester T, McFarlane-Anderson N, Bennett FI, et al. The angiotensin converting enzyme and blood pressure in Jamaicans. Am J Hypertens 1997;10(5 Pt 1):519-24.
13. Samuelsson O, Attman PO, Larsson R, et al. Angiotensin I-converting enzyme gene polymorphism in non-diabetic renal disease. Nephrol Dial Transplant 2000;15:481-6.
14. Henderson SO, Coetzee GA, Ross FK, et al. Elevated mortality rates from circulatory disease in African American men and women of Los Angeles County, California - a possible genetic susceptibility? Am J Med Sci 2000;320:18-23.
15. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-4.
16. Schunkert H, Hense HW, Holmer SR, et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994;330:1634-8.
17. Raynolds MV, Bristow MR, Bush EW, et al. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 1993;342:1073-5.
18. Lindpaintner K, Pfeffer MA, Kreutz R, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-11.
19. Fujisawa T, Ikegami H, Shen GQ, et al. Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 1995;18:983-5.
20. Feng Y, Niu T, Xu X, et al. Insertion/deletion polymorphism of the ACE gene is associated with type 2 diabetes. Diabetes 2002;51:1986-8.
21. Rabensteiner D, Abrahamian H, Irsigler K, et al. ACE gene polymorphism and proliferative retinopathy in type I diabetes: results of a case-control study. Diabetes Care 1999;22:1530-5.
22. Jeunemaitre X, Lifton RP, Hunt SC, et al. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet 1992;1:72-5.
23. Freedman BI, Tuttle AB, Spray BJ. Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. Am J Kidney Dis 1995;25:710-3.
24. Satko SG, Langefeld CD, Daeihagh P, et al. Nephropathy in siblings of African Americans with overt type 2 diabetic nephropathy. Am J Kidney Dis 2002;40:489-94.
25. Yu H, Bowden DW, Spray BJ, et al. Linkage analysis between loci in the renin-angiotensin axis and end-stage renal disease in African Americans. J Am Soc Nephrol 1996;7:2559-64.
26. Kohler KA, McClellan WM, Ziemer DC, et al. Risk factors for microalbuminuria in black Americans with newly diagnosed type 2 diabetes. Am J Kidney Dis 2000;36:903.
27. Garza R, Median R, Basu S, Pugh JA. Predictors of the rate of renal function decline in non-insulin-dependent diabetes mellitus. Am J Nephrol 1997;17:59-67.
28. Krolewski AS. Genetics of diabetic nephropathy: evidence for major and minor gene effects. Kidney Int 1999;55:1582-96.
29. Solini A, Dalla Vestra M, Saller A, et al. The angiotensin-converting enzyme DD genotype is associated with glomerulopathy lesions in type 2 diabetes. Diabetes 2002;51:251-5.